Challenge

Following BioE's discovery and commercialization of its Multi-Lineage Progenitor Cell™ (MLPC™) — a rare stem cell derived from human umbilical cord blood — build credibility for the MLPC among therapeutic researchers, clinicians and pharmaceutical companies. Educate them about its potential to significantly enhance stem cell research by enabling advanced studies, screens and tests with greater potential for human therapeutic and pharmaceutical applications. Generate exposure for BioE among investors as it competes with other emerging biotech companies for funding.

Solution

Develop key messages and media kit. Provide media training to spokespeople. Distribute news releases about product and corporate developments, strategic partnerships and new discoveries to trade (science, medical), consumer and business media. Continuously inform reporters about the significance of BioE’s corporate and product milestones. Currently developing tagline and assisting with Web site revamp.

Results

Coverage of BioE or BioE executives in Inc. and on CBS Radio, as well as nearly every Twin Cities business outlet, including Minnesota Public Radio, Minneapolis Star Tribune, St. Paul Pioneer Press, Minneapolis-St. Paul Business Journal, Minnesota Business, Minnesota Technology and Twin Cities Business Monthly. Extensive coverage in trade media, such as Nature Biotechnology, Genetic Engineering News, Stem Cell Research News, PharmaVOICE and BioWorld Today. Placements have generated numerous inquiries to BioE from science and medical professionals and investors asking for additional information.

Feedback

Mike Haider, president and CEO of BioE: “Haberman & Associates has been an important partner in implementing our strategy to build greater company awareness. I have been thoroughly impressed with their professionalism, creativity and ability to quickly master the technical nuances of our business.”